Fig. 2From: Characterizing the metabolic divide: distinctive metabolites differentiating CAD-T2DM from CAD patientsForest plot of characteristic plasma metabolites associated with T2DM risk in CAD patients. (Discovery cohort FDR < 0.05, Validation cohort P < 0.05). Multivariate logistic regression in the discovery A and validation B cohorts, adjusted for age, ALT, AST, BMI, eGFR, hypertension, hyperlipidemia, and genderBack to article page